JunLiuMD

Pathology • Modesto, CA

Anatomic Pathology, Clinical Pathology

Assistant Professor, Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Liu's full profile

Already have an account?

Office
4601 Dale Road
Modesto, CA 95355
Phone+1 209-435-6000

Fax+1 209-435-6050

Education & Training

Temple University Hospital/Fox Chase Cancer Center Surgical PathologyFellowship, Selective Pathology, 2004 - 2005
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Pathology-Anatomic and Clinical, 2000 - 2004
Shanghai Medical UniversityClass of 1991

Certifications & Licensure

CA State Medical License 2014 - 2026
NJ State Medical License 2004 - 2019
NY State Medical License 2011 - 2019
PA State Medical License 2001 - 2018
KY State Medical License 2013 - 2014
OH State Medical License 2013 - 2014
American Board of Pathology Anatomic Pathology & Clinical Pathology

Clinical Trials

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection Start of enrollment: 2020 Oct 17
Recruiting
Early Phase 1
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies Start of enrollment: 2020 Sep 01
Recruiting
Phase 2

Publications & Presentations

PubMed

9 citations
PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein.
Scott M Johnson, Hanmei Bao, Cailin E McMahon, Yongbin Chen, Stephanie D Burr
Nature Communications. 2024-06-06
3 citations
Replacement of saturated fatty acids with linoleic acid in western diet attenuates atherosclerosis in a mouse model with inducible ablation of hepatic LDL receptor.
Stephanie D Burr, Yongbin Chen, Christopher P Hartley, Xianda Zhao, Jun Liu
Scientific Reports. 2023-10-06
9 citations
HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia.
Davide Povero, Yongbin Chen, Scott M Johnson, Cailin E McMahon, Meixia Pan
Journal of Hepatology. 2023-08-01